ARTERIAL HYPERTENSION DURING THERAPY OF ONCOLOGICAL DISEASES WITH ANGIOGENESIS INHIBITORS: SERIOUS IMPEDIMENT OR CONTROLLED REACTION?
Vascular endothelial growth factor signaling pathway (VSP) inhibitors are drugs for which arterial hypertension (AH) is a class effect, occurring with a frequency of up to 73 % of treated patients. Blockade of vascular endothelial growth factor or its receptor is accompanied by inhibition of the syn...
Saved in:
Main Authors: | Zh. D. Kobalava, E. K. Shavarova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2017-06-01
|
Series: | Опухоли головы и шеи |
Subjects: | |
Online Access: | https://ogsh.abvpress.ru/jour/article/view/268 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer
by: S. V. Khokhlova
Published: (2014-08-01) -
Changes in angiogenesis markers during neoadjuvant treatment for locally advanced breast cancer
by: E. A. Kim, et al.
Published: (2014-08-01) -
Various doses of statins and coronary angiogenesis in patients with coronary heart disease
by: I. V. Sergienko, et al.
Published: (2009-10-01) -
Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models
by: Masahiro Matsuki, et al.
Published: (2018-06-01) -
Angiogenesis in endometrial cancer: clinical and biological significance
by: I. V. Maiborodin, et al.
Published: (2024-09-01)